These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31284931)

  • 1. Biologics for Asthma and Risk of Infection: Cause for Concern?
    Lopes JP; Desai M
    Immunol Allergy Clin North Am; 2019 Aug; 39(3):429-445. PubMed ID: 31284931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of Biologics in Severe Asthma: A Multifaceted Algorithm.
    Dávila I; Quirce S; Olaguibel JM
    J Investig Allergol Clin Immunol; 2019; 29(4):325-328. PubMed ID: 30969172
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging Biologics in Severe Asthma.
    Pavord ID; Hilvering B; Shrimanker R
    Immunol Allergy Clin North Am; 2016 Aug; 36(3):609-23. PubMed ID: 27401629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do biologicals and other novel therapies effect clinically used biomarkers in severe asthma?
    Upham JW; Jurak LM
    Clin Exp Allergy; 2020 Sep; 50(9):994-1006. PubMed ID: 32569412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A drug safety review of treating eosinophilic asthma with monoclonal antibodies.
    Mitchell P; Leigh R
    Expert Opin Drug Saf; 2019 Dec; 18(12):1161-1170. PubMed ID: 31594389
    [No Abstract]   [Full Text] [Related]  

  • 6. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics in the treatment of severe asthma.
    Quirce S; Phillips-Angles E; Domínguez-Ortega J; Barranco P
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():45-49. PubMed ID: 29108767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe T2-high asthma in the biologics era: European experts' opinion.
    Pavord I; Bahmer T; Braido F; Cosío BG; Humbert M; Idzko M; Adamek L
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics or immunotherapeutics for asthma?
    Tay HL; Foster PS
    Pharmacol Res; 2020 Aug; 158():104782. PubMed ID: 32275962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological treatments for severe asthma: A major advance in asthma care.
    Busse WW
    Allergol Int; 2019 Apr; 68(2):158-166. PubMed ID: 30792118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives of childhood asthma treatment with biologics.
    Just J; Deschildre A; Lejeune S; Amat F
    Pediatr Allergy Immunol; 2019 Mar; 30(2):159-171. PubMed ID: 30444939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the current role of biologics in the management of patients with severe refractory asthma?
    Draikiwicz S; Oppenheimer J
    Ann Allergy Asthma Immunol; 2016 May; 116(5):383-7. PubMed ID: 27153737
    [No Abstract]   [Full Text] [Related]  

  • 14. Asthma biologics: Comparing trial designs, patient cohorts and study results.
    Doroudchi A; Pathria M; Modena BD
    Ann Allergy Asthma Immunol; 2020 Jan; 124(1):44-56. PubMed ID: 31655122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are biological drugs effective and safe in older severe asthmatics?
    Benfante A; Principe S; Battaglia S; Scichilone N
    Expert Opin Drug Saf; 2019 May; 18(5):369-380. PubMed ID: 30983432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of choosing the correct biologic for the correct asthma patient.
    Sriaroon P; Casale TB
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):385-386. PubMed ID: 30290891
    [No Abstract]   [Full Text] [Related]  

  • 17. Responses to Biological Therapy in Severe Eosinophilic Asthma.
    Alvarez-Puebla MJ; Arroabarren E; Zavala MJ; Corcuera A; Olaguibel A; Olaguibel JM
    J Investig Allergol Clin Immunol; 2019; 29(4):335-337. PubMed ID: 30990776
    [No Abstract]   [Full Text] [Related]  

  • 18. Biologics in asthma--the next step toward personalized treatment.
    Darveaux J; Busse WW
    J Allergy Clin Immunol Pract; 2015; 3(2):152-60; quiz 161. PubMed ID: 25754716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future biologic therapies in asthma.
    Quirce S; Bobolea I; Domínguez-Ortega J; Barranco P
    Arch Bronconeumol; 2014 Aug; 50(8):355-61. PubMed ID: 24685200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New guidelines and new therapy options in severe asthma].
    Einecke D
    MMW Fortschr Med; 2016 May; 158(9):18-9. PubMed ID: 27155682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.